Mehta Swati, Chauhan Kinsuk, Patel Achint, Patel Shanti, Pinotti Rachel, Nadkarni Girish N, Parikh Chirag R, Coca Steven G
Albany Medical center, 25 Hackett Blvd, Albany, NY, 12208, USA.
Icahn School of Medicine at Mount Sinai, New York, NY, USA.
BMC Nephrol. 2018 Apr 19;19(1):91. doi: 10.1186/s12882-018-0876-7.
Acute kidney injury (AKI), as defined by peak increase in serum creatinine, is independently associated with increased risk of mortality and length of stay. Studies have suggested that the duration of AKI may be an important additional or independent prognostic marker of increased mortality in patients with AKI across clinical settings. We performed a systematic review and meta-analysis of published studies to assess the impact of duration of AKI on outcomes.
Various bibliographic databases (MEDLINE, Embase, Cochrane Library, CINAHL and Web of Science) were searched through database inception to December 2015. Human, longitudinal studies with patients aged 18 or above describing outcomes of duration of AKI were included. Duration of AKI categorized as "Short" if AKI duration was ≤2 days or labeled as "transient AKI"; "Medium" for AKI durations 3-6 days and "Long" for AKI duration of ≥7 days or "non-recovered". Various outcomes looked at were Long term mortality, cardiovascular events, chronic kidney disease (CKD).
Eighteen studies were deemed eligible for the systematic review. The outcome of long-term mortality with duration of AKI was reported in 8 studies. The pooled Risk Ratio (RR) for long-term mortality generally was higher for longer duration of AKI: short duration of AKI (n = 8 studies, RR 1.42, 95% CI 1.21-1.66), medium duration (n = 4 studies, RR 1.92, 95% CI 1.34-2.75), and long duration (n = 8 studies, RR 2.28, 95% CI 1.77-2.94) duration of AKI. Further, Duration of AKI was independently associated with higher risk of cardiovascular outcomes and incident CKD Stage 3 when stratified within each stage of AKI.
Duration of AKI was independently associated with long term mortality, cardiovascular(CV) events, and development of incident CKD Stage 3.
急性肾损伤(AKI),以血清肌酐峰值升高来定义,与死亡率增加和住院时间独立相关。研究表明,在各种临床情况下,AKI的持续时间可能是AKI患者死亡率增加的一个重要的附加或独立预后指标。我们对已发表的研究进行了系统评价和荟萃分析,以评估AKI持续时间对预后的影响。
检索各种文献数据库(MEDLINE、Embase、Cochrane图书馆、CINAHL和科学网),检索时间从数据库建立至2015年12月。纳入针对18岁及以上患者、描述AKI持续时间结局的纵向研究。如果AKI持续时间≤2天,则将AKI持续时间分类为“短”,或标记为“短暂性AKI”;AKI持续3 - 6天为“中”,AKI持续时间≥7天或“未恢复”为“长”。观察的各种结局包括长期死亡率、心血管事件、慢性肾脏病(CKD)。
18项研究被认为符合系统评价的条件。8项研究报告了AKI持续时间与长期死亡率的结局。AKI持续时间较长时,长期死亡率的合并风险比(RR)通常更高:AKI持续时间短(n = 8项研究,RR 1.42,95%CI 1.21 - 1.66)、中等持续时间(n = 4项研究,RR 1.92,95%CI 1.34 - 2.75)、长持续时间(n = 8项研究,RR 2.28,95%CI 1.77 - 2.94)的AKI。此外,在AKI的每个阶段分层时,AKI持续时间与心血管结局和CKD 3期发病的较高风险独立相关。
AKI持续时间与长期死亡率、心血管(CV)事件以及CKD 3期发病独立相关。